Investor Presentation

Here's a summary of Navin Fluorine International Limited's latest investor presentation: **Financial Highlights:** Navin Fluorine's Q1 FY26 consolidated sales reached Rs 725.4 Cr (+39% YoY). Operating EBITDA hit Rs 206.8 Cr (+106% YoY), with margin at 28.5% (+935 bps YoY). Profit After Tax surged 129% YoY to Rs 117.17 Cr, driven by robust growth across all business segments. **Strategic Initiatives & Growth Drivers:** Key capex projects are on track: AHF plant (Rs 450 Cr) at Dahej expected by Q2 FY26 and cGMP4 Phase 1 (Rs 160 Cr) by Q3 FY26. The R32 plant is now optimally utilized.

Significant R&D investment continues, aimed at expanding fluorinated specialty chemicals and new-age products. **Business Developments:** A strategic partnership with Chemours for Advanced Materials has commenced.

Three new specialty molecules are set for supply in Q2 FY26. The CDMO segment secured a material order from an EU major and anticipates further global commercial/scale-up orders, enhancing future revenue visibility. **Market Position & Competitive Advantage:** The company operates a resilient, diversified business model as a preferred global fluorochemicals partner.

It leverages India's largest fluorination facilities, backward integration, and a "one-stop" provider approach, reinforcing its market leadership and competitive strengths. **Investor Implications:** The excellent Q1 performance, coupled with significant capacity expansions and a strong pipeline of new orders and molecules, signals positive growth potential.

The company's strategic R&D and diversified offerings position it for continued strong financial performance.